Literature DB >> 26928292

23 years of toxicology testing fatally injured pilots: Implications for aviation and other modes of transportation.

Mary Pat McKay1, Loren Groff2.   

Abstract

UNLABELLED: Use of over-the-counter, prescription, and illicit drugs is increasing in the United States (US). Many of these drugs are psychoactive and can affect the user's ability to safely operate a vehicle. However, data about drug use by vehicle operators is typically limited to a small proportion of operators and a short list of drugs. For instance, required testing for commercial vehicle operators following most accidents is limited to a urine test for 11 drugs. By comparison, the Federal Aviation Administration (FAA), routinely tests fatally injured pilots' blood and tissues for hundreds of compounds. This study used the results from these tests to assess drug use in aviation.
METHODS: Using matched data from the FAA's Civil Aerospace Medical Institute toxicology database and the National Transportation Safety Board's (NTSB's) aviation accident database, this study examined trends in the prevalence of over-the-counter, prescription, and illicit drugs identified in toxicology tests of fatally injured pilots between 1990 and 2012. Cases that failed to match or where toxicology testing had not been performed were excluded. Pilots identified by the NTSB investigation as being the "flying pilot" at the time of the accident and results from blood or tissues were included. Toxicology results for ethanol and other alcohols were not included. Positive test results were categorized by drug type and potential for causing impairment. Analysis used SPSS Version 19.1 to perform linear by linear chi-squared statistics.
RESULTS: The study included 6677 pilots or 87% of the eligible subjects. The large majority were male (98%) and flying general aviation operations (96%) at the time of their fatal accident. There were increasing trends in pilots' use of all drugs, potentially impairing drugs, drugs used to treat potentially impairing conditions, drugs designated as controlled substances, and illicit drugs. The most common potentially impairing drug pilots had used was diphenhydramine, a sedating antihistamine that is an active ingredient in many over-the-counter allergy formulations, cold medicines, and sleep aids in the US. Although evidence of illicit drug use was found only in a small number of cases, the percentage of pilots testing positive for marijuana use increased during the study period, mostly in the last 10 years. Published by Elsevier Ltd.

Entities:  

Keywords:  Aviation; Crash risk; Drugs; Medications; Post-accident toxicology testing; Safety; Transportation

Mesh:

Substances:

Year:  2016        PMID: 26928292     DOI: 10.1016/j.aap.2016.02.008

Source DB:  PubMed          Journal:  Accid Anal Prev        ISSN: 0001-4575


  8 in total

1.  US Adult Illicit Cannabis Use, Cannabis Use Disorder, and Medical Marijuana Laws: 1991-1992 to 2012-2013.

Authors:  Deborah S Hasin; Aaron L Sarvet; Magdalena Cerdá; Katherine M Keyes; Malka Stohl; Sandro Galea; Melanie M Wall
Journal:  JAMA Psychiatry       Date:  2017-06-01       Impact factor: 21.596

Review 2.  Cannabis use, attitudes, and legal status in the U.S.: A review.

Authors:  Hannah Carliner; Qiana L Brown; Aaron L Sarvet; Deborah S Hasin
Journal:  Prev Med       Date:  2017-07-11       Impact factor: 4.018

Review 3.  Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings.

Authors:  Deborah S Hasin; Dvora Shmulewitz; Aaron L Sarvet
Journal:  Am J Drug Alcohol Abuse       Date:  2019-03-14       Impact factor: 3.829

Review 4.  Towards definitive management of allergic rhinitis: best use of new and established therapies.

Authors:  Lubnaa Hossenbaccus; Sophia Linton; Sarah Garvey; Anne K Ellis
Journal:  Allergy Asthma Clin Immunol       Date:  2020-05-27       Impact factor: 3.406

5.  Multimodal Approach for Emotion Recognition Based on Simulated Flight Experiments.

Authors:  Válber César Cavalcanti Roza; Octavian Adrian Postolache
Journal:  Sensors (Basel)       Date:  2019-12-13       Impact factor: 3.576

Review 6.  Allergic Rhinitis: A Clinical and Pathophysiological Overview.

Authors:  Siti Muhamad Nur Husna; Hern-Tze Tina Tan; Norasnieda Md Shukri; Noor Suryani Mohd Ashari; Kah Keng Wong
Journal:  Front Med (Lausanne)       Date:  2022-04-07

7.  US Epidemiology of Cannabis Use and Associated Problems.

Authors:  Deborah S Hasin
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

Review 8.  CSACI position statement: Newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria.

Authors:  Michael N Fein; David A Fischer; Andrew W O'Keefe; Gord L Sussman
Journal:  Allergy Asthma Clin Immunol       Date:  2019-10-01       Impact factor: 3.406

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.